Berlin Heals Holding AG, a Zurich, Switzerland-based developer of implantable medical device for the cure of heart failure, closed a second funding round.
The amount of the deal was not disclosed.
The company intends to use the funds to finalize all the necessary system verification activities and to begin a First-in-Man clinical trial within the next months.
Led by Dr. Johannes Müller and and Dr. Peter Göttel, Berlin Heals Holding is advancing an implantable medical device for the cure of heart failure. The so called Berlin Heals C-MIC (Cardiac Microcurrent) System is a new method for the treatment of the disease via the direct application of electrical microcurrent to heart muscle tissue.
Berlin Heals Holding operates an ISO-certified research & development subsidiary in Berlin.
FinSMEs
12/09/2016